Clinical Trial Update: Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating preoperative and adjuvant therapy with carboplatin, nab-paclitaxel, and durvalumab for head and neck squamous cell carcinoma; status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Head and Neck Squamous Cell Carcinoma
• Laryngeal Cancer
• Lip Cancer
• Oral Cancer
• Oropharyngeal Cancer

Drugs mentioned

• Abraxane (nab-paclitaxel) (nab-paclitaxel)
• CARBOPLATIN (Carboplatin)
• Durvalumab (durvalumab)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Carcinoma, Squamous Cell, Oral Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-02-08